Cigarette smoking and health characteristics in individuals with serious mental illness enrolled in a behavioral weight loss trial

Journal of Dual Diagnosis

Volumn 9, Issue 1, 2013, Pages 39-46

  Dickerson, Faith B ^a   Yu, Airong ^b   Dalcin, Arlene ^c   Jerome, Gerald J ^c,d   Gennusa, Joseph V ^c   Charleston, Jeanne ^e   Crum, Rosa M ^b,c,e,f   Campbell, Leslie ^b,c   Oefinger, Meghan ^c   Appel, Lawrence J ^b,c,e   Daumit, Gail L ^b,c,e,f,g  

^a Sheppard Pratt   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TOWSON UNIVERSITY   (United States)

^e Johns Hopkins Bloomberg   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cardiovascular; Health; Serious mental illness; Smoking; Weight loss

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; EDUCATIONAL STATUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; OBESITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

EID: 84876230275     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1080/15504263.2012.749829     Document Type: Article

References (39)

1. American Lung Association. (2011). Trends in tobacco use. Retrieved from http://www.lung.org/finding-cures/our-research/trend-reports/ Tobacco-Trend-Report.pdf
2. Appel, L. J., Sacks, F. M., Carey, V. J., Obarzanek, E., Swain, J. F., Miller, E. R. III. & OmniHeart Collaborative Research Group. (2005). Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the OmniHeart randomized trial. JAMA: The Journal of the American Medical Association, 294(19), 2455-2464. doi:10.1001/jama.294.19. 2455
3. Baker, A., Richmond, R., Haile, M., Lewin, T. J., Carr, V. J., Taylor, R. L., & Moeller-Saxone, K. (2007). Characteristics of smokers with a psychotic disorder and implications for smoking interventions. Psychiatry Research, 150(2), 141-152. doi:10.1016/j.psychres.2006.05.021
4. Block, G., Gillespie, C., Rosenbaum, E. H., & Jenson, C. (2000). A rapid food screener to assess fat and fruit and vegetable intake. American Journal of Preventative Medicine, 18(4), 284-288. doi:10.1016/S0749-3797(00) 00119-7
5. Bobes, J., Arango, C., Garcia-Garcia, M., & Rejas, J. (2010). Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophrenia Research, 119(1-3), 101-109. doi:10.1016/j.schres.2010.02.1030
6. Bobes, J., García-Portilla, P., Sáiz, P. A., Bascarán, T., & Bousoño, M. (2005). Quality of life measures in schizophrenia. European Psychiatry, 20(Suppl 3), S313-S317. doi:10.1016/S0924-9338(05)80182-8
7. Casagrande, S. S., Jerome, G. J., Dalcin, A. T., Dickerson, F. B., Anderson, C. A., Appel, L. J., Daumit, G. L. (2010). Randomized trial of achieving healthy lifestyles in psychiatric rehabilitation: The ACHIEVE trial. BMC Psychiatry, 10, 108-120. doi:10.1186/1471-244X-10-108
8. Centers for Disease Control. (2004). Cigarette smoking among adults-United States, 2002. Morbidity and Mortality Weekly Report, 53(20), 427-431. Retrieved from http://www.cdc.gov/mmwr/mmwr wk/wk pvol.html
9. Centers for Disease Control. (2011a). Vital signs: Current cigarette smoking among adults aged =18 years-United States, 2005-2010. Morbidity and Mortality Weekly, 60(35), 1207-1212. Retrieved from http://www.cdc.gov/mmwr/mmwr wk/wk pvol.html
10. Centers for Disease Control. (2011b). Chronic disease prevention and health promotion. Tobacco use: Targeting the nation's leading killer at a glance 2011. Retrieved from http://www.cdc.gov/chronicdisease/resources/publications/ aag/osh.htm
11. Chelland Campbell, S., Moffatt, R. J., & Stamford, B. A. (2008). Smoking and smoking cessation-The relationship between cardiovascular disease and lipoprotein metabolism: A review. Atherosclerosis, 201(2), 225-235. doi:10.1016/j.atherosclerosis.2008.04.046
12. Compton, M. T., Daumit, G. L., & Druss, B. G. (2006). Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: A preventive perspective. Harvard Review of Psychiatry, 14(4), 212-222. doi:10.1080/10673220600889256
13. Curkendall, S. M., Mo, J., Glasser, D. B., Rose Stang, M., & Jones, J. K. (2004). Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada. Journal of Clinical Psychiatry, 65, 715-720. doi:10.1016/j.annepidem.2005.04.008
14. D'Agostino, R. B. Sr, Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008). General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation, 117(6), 743-753. doi:10.1161/CIRCULATIONAHA.107.699-579
15. de Leon, J., & Diaz, F. J. (2012). Genetics of schizophrenia and smoking: An approach to studying their comorbidity based on epidemiological findings. Human Genetics. 131(6), 877-901. doi:10.1007/s00439-011-1122-6
16. Diaz, F. J., James, D., Botts, S., Maw, L., Susce, M. T., & de Leon, J. (2009). Tobacco smoking behaviors in bipolar disorder: A comparison of the general population, schizophrenia, and major depression. Bipolar Disorder, 11(2), 154-165. doi:10.1111/j.1399-5618.2009.00664
17. Dickerson, F., Bennett, M.,Dixon, L., Burke, E.,Vaughan, C.,Delahanty, J.,& DiClemente, C. (2011). Smoking cessation in persons with serious mental illnesses: The experience of successful quitters. Psychiatric Rehabilitation Journal, 34(4), 311-316. doi:10.2975/34.4.2011.311.316
18. Dixon, L., Medoff, D. R., Wohlheiter, K., DiClemente, C., Goldberg, R., Kreyenbuhl, J., & Davin, C. (2007). Correlates of severity of smoking among persons with severe mental illness. American Journal of Addictions, 16(2), 101-110. doi:10.1080/10550490601184415
19. Eisen, S. V., Normand, S. L., Belanger, A. J., Spiro, A. III, & Esch, D. (2004). The Revised Behavior and Symptom Identification Scale (BASIS-R): Reliability and validity. Medical Care, 42(12), 1230-1241. doi:10.1097/00005650- 200412000-00010
20. Erhardt, L. (2009). Cigarette smoking: An undertreated risk factor for cardiovascular disease. Atherosclerosis, 205, 23-32. doi:10.1016/j. atherosclerosis.2009.01.007
21. Framingham Heart Study. (2008). General cardiovascular disease (10 year risk). Retrieved from http://www.framinghamheartstudy.org/risk/gencardio.html
22. Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., & Lieberman, J. A. (2005). A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia Research, 80, 45-53. doi:10.1016/j.schres.2005. 08.010
23. Gossett, L. K., Johnson, H. M., Piper, M. E., Fiore, M. C., Baker, T. B., & Stein, J. H. (2009). Smoking intensity and lipoprotein abnormalities in active smokers. Journal of Clinical Lipidology, 3(6), 372-378. doi:10.1016/j.jacl.2009.10.008
24. Hughes, J. R., Hatsukami, D. K, Mitchell, J. E., & Dahlgren, L. A. (1986). Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry, 143(8), 993-997.
25. Jenkinson, C., Layte, R., Jenkinson, D., Lawrence, K., Petersen, S., Paice, C., & Stradling, J. (1997). A shorter form health survey: Can the SF-12 replicate results from the SF-36 in longitudinal studies? Journal of Public Health Medicine, 19(2), 179-186.
26. Lasser, K., Boyd, J. W., Woolhandler, S., Himmelstein, D. U., McCormick, D., & Bor, D. H. (2000). Smoking and mental illness: A populationbased prevalence study. JAMA: The Journal of the American Medical Association, 284, 2606-2610. doi:10.1001/jama.284.20.2606
27. Margolese, H. C., Malchy, L., Negrete, J. C., Tempier, R., & Gill, K. (2004). Drug and alcohol use among patients with schizophrenia and related psychoses: Levels and consequences. Schizophrenia Research, 67, 157-166. doi:10.1016/S0920-9964(02)00523-6
28. McClave, A. K., McKnight-Eily, L. R., Davis, S. P., & Dube, S. R. (2007). Smoking characteristics of adults with selected lifetime mental illnesses: Results from the 2007 National Health Interview Survey. American Journal of Public Health, 100(12), 2464-2472. doi:10.2105/AJPH.2009.188136
29. Montoya, I. D., Herbeck, D. M., Svikis D. S., & Pincus, H. A. (2005). Identification and treatment of patients with nicotine problems in routine clinical psychiatry practice. American Journal on Addictions, 14, 441-454. doi:10.1080/10550490500247123
30. Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401. doi:10.1177/014662167700100306
31. Tidey, J. W., Rohsenow, D. J., Kaplan, G. B., & Swift, R. M. (2005). Cigarette smoking topography in smokerswith schizophrenia andmatched non-psychiatric controls. Drug and Alcohol Dependence, 80, 259-265. doi:10.1016/j.drugalcdep.2005.04.002
32. Virdis, A., Giannarelli, C., Neves, M. F., Taddei, S., & Ghiadoni, L. (2010). Cigarette smoking and hypertension. Current Pharmaceutical Design, 16(23), 2518-2525. doi:10.2174/138161210792062920
33. Vollmer,W.M., Appel, L. J., Svetkey, L. P., Moore, T. J., Vogt, T.M., Conlin, P. R., & DASH Collaborative Research Group. (2005). Comparing officebased and ambulatory blood pressure monitoring in clinical trials. Journal of Human Hypertension, 19, 77-82. doi:10.1038/sj.jhh.1001772
34. White,W. B., & Anwar, Y. A. (2001). Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monitor, 6(2), 107-110. doi:10.1097/00126097-200104000-00007
35. Willi, C., Bodenmann, P., Ghali, W. A., Faris, P. D., & Cornuz, J. (2007). Active smoking and the risk of type 2 diabetes: A systematic review and meta-Analysis. JAMA: The Journal of the American Medical Association, 298, 2654-2664. doi:10.1001/jama.298.22.2654
36. Williams, J. M., Ziedonis, D. M., Abanyie, F., Steinberg, M. L., Foulds, J., & Benowitz, N. L. (2005). Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophrenia Research, 79, 323-335.
37. Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Riley, W. T. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine and Tobacco Research, 10(12), 1691-1715. doi:10.1080/14622200802443569
38. Ziedonis, D. M.,Kosten, T.R., Glazer,W.M.,&Frances,R. J. (1994).Nicotine dependence and schizophrenia. Hospital & Community Psychiatry, 45(3), 204-206.
39. Ziedonis, D. M., Smelson, D., Rosenthal, R. N., Batki, S. L., Green, A. I., Henry, R. J.,&Weiss, R. D. (2005). Improving the care of individuals with schizophrenia and substance use disorders: Consensus recommendations. Journal of Psychiatric Practice, 11, 315-339.